Candriam SCA’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-179,850	Closed	-$1.09M	–	918
2022 Q4	$1.09M	Buy	179,850 +54,231	+43%	+$328K	0.01%	684
2022 Q3	$830K	Buy	+125,619	New	+$830K	0.01%	753